Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities
- 24 August 2010
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 70 (1), 188-193
- https://doi.org/10.1136/ard.2010.131102
Abstract
Objective Anti-citrullinated protein antibodies (ACPA) and anti-cyclic citrullinated peptide (anti-CCP) antibodies are a hallmark of rheumatoid arthritis and are believed to play a role in disease pathogenesis. These antibodies are typically detected in ELISA with citrullinated peptides (eg, CCP2) or proteins as antigens. The absolute concentration of anti-CCP antibodies in serum is unknown. Although antibodies to several citrullinated proteins can mainly be detected within anti-CCP-positive sera, it is currently unknown whether anti-CCP antibodies are in fact ACPA. Likewise, it is unknown to what extent antibody responses to different citrullinated antigens are crossreactive. Methods An affinity purification method was established in which citrullinated antigen-specific antibodies were eluted from ELISA plates and then used for detection of other citrullinated antigens in ELISA or western blot. For additional crossreactivity studies, ELISA-based inhibition assays were performed with citrullinated or control peptides as inhibitors. Results The concentration of anti-CCP IgG antibodies was estimated to be at least 30 mu g/ml in patients with high anti-CCP levels (> 1600 mu g/ml). Affinity-purified anti-CCP antibodies were able to recognise citrullinated fibrinogen (cit-fib) and citrullinated myelin basic protein (cit-MBP) on western blot. Furthermore, antibodies specific for cit-fib and cit-MBP were crossreactive. However, additional crossreactivity studies indicated that non-overlapping antibody responses to citrullinated peptides can also exist in patients. Conclusions This report shows for the first time that anti-CCP antibodies recognise multiple citrullinated proteins and are thus a collection of ACPA. More importantly, the data indicate that different ACPA responses are crossreactive, but that crossreactivity is not complete, as distinct non-crossreactive responses can also be detected in patients with RA.Keywords
This publication has 17 references indexed in Scilit:
- Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritisAnnals Of The Rheumatic Diseases, 2010
- Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patientsArthritis & Rheumatism, 2009
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisThe Journal of Experimental Medicine, 2009
- Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 allelesAnnals Of The Rheumatic Diseases, 2008
- Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogenArthritis & Rheumatism, 2008
- Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to VaccinesJournal of Clinical Immunology, 2007
- Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisArthritis & Rheumatism, 2007
- Epitopes of human fibrin recognized by the rheumatoid arthritis‐specific autoantibodies to citrullinated proteinsEuropean Journal of Immunology, 2006
- Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritisJCI Insight, 2006
- Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritisAnnals Of The Rheumatic Diseases, 2005